Get Your Personalized Supplement StackSupplement Stack Quiz

Akba

Also known as: AKBA, 3-O-Acetyl-11-Keto Boswellic Acid, Beta-Boswellic Acid, 3-O-Acetyl-11-Keto Beta-Boswellic Acid (AKBA)

Overview

3-O-Acetyl-11-Keto Beta-Boswellic Acid (AKBA) is a pentacyclic triterpenoid derived from the resin of *Boswellia serrata*, also known as frankincense. It possesses significant anti-inflammatory, antioxidant, and anti-tumor properties, making it a promising candidate for therapeutic use against various health issues, particularly osteoarthritis and neuroinflammatory conditions. Notably, AKBA inhibits the enzyme 5-lipoxygenase, thereby reducing the production of leukotrienes that contribute to inflammation. The current evidence base includes high-quality clinical trials and systematic reviews, affirming its potential for health improvements in conditions characterized by inflammatory responses.

Benefits

AKBA demonstrates impressive anti-inflammatory properties, with clinical studies reporting a pain reduction of up to 61.9% in osteoarthritis patients taking 300 mg daily over a 90-day period. Additionally, it possesses neuroprotective effects that reduce neuroinflammation and can enhance cognitive functions in animal studies. Its anti-tumor effects are linked to the inhibition of topoisomerase activity, and its antioxidant properties help mitigate oxidative stress levels. Populations suffering from osteoarthritis and neurodegenerative diseases experience the most significant benefits from AKBA supplementation, solidifying its role as a valuable adjunctive treatment.

How it works

AKBA primarily functions by inhibiting the enzyme 5-lipoxygenase, crucial for leukotriene production which mediates inflammatory responses. Additionally, it affects topoisomerase I and IIa enzymes, leading to apoptosis in cancer cells. Through these actions, AKBA decreases inflammatory cytokines such as TNFα, hs-CRP, and IL-6, thereby modulating immune responses and contributing to neuroprotective effects.

Side effects

AKBA is generally considered safe, with clinical trials noting no significant adverse effects. Side effects are reported to occur at rates below 5%, with no major rare events documented. However, individuals concurrently using anti-inflammatory or anticoagulant medications should exercise caution, as comprehensive data on potential interactions is lacking. While no specific contraindications exist, individuals with allergies to Boswellia species are advised to avoid its use. Pregnant or breastfeeding women should consult a healthcare provider before starting AKBA, as safety data for these populations is not well-established.

Dosage

The typical effective dosage of AKBA ranges from 150 mg to 300 mg per day, with promising results observed at these levels in clinical studies. For optimal absorption, it is advisable to take AKBA divided into two doses, ideally after breakfast and dinner. Although there is no clearly defined upper limit for safe dosage, the administration of up to 300 mg has not correlated with adverse effects. Taking AKBA with meals can enhance its bioavailability. It is most commonly available in tablet or capsule form, highlighting the importance of solubility for effective absorption.

FAQs

Is AKBA safe?

Yes, AKBA is generally considered safe, but individuals should consult healthcare providers if they have underlying health conditions or are taking other medications.

When should I take AKBA?

AKBA should be taken after meals, preferably in two divided doses for better absorption.

When can I expect results from AKBA supplementation?

Users can expect improvements in pain and inflammation markers within a few days to weeks of consistent supplementation.

Is AKBA a cure for inflammatory conditions?

AKBA is not a cure-all but works effectively as a complementary therapy for various inflammatory conditions.